Unknown × Observational × Carcinoma, Ovarian Epithelial × Clear all Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease
Unknown
45 enrolled
SUROVA
Unknown
5,000 enrolled
Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study
Unknown
1,000 enrolled
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
Unknown
20 enrolled
OutCoME
Unknown
75 enrolled
Chromosomal Instability in Ovarian Cancer
Unknown
300 enrolled
HRD and Resistance to PAPPi in EOC Patients
Unknown
400 enrolled
RENI-1
Unknown
300 enrolled
A Training Set for the HRD Model in EOC
Unknown
200 enrolled
Genetic Mutation in Epithelial Ovarian Cancer
Unknown
500 enrolled
Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer
Unknown
1,300 enrolled
A Genomic Analysis of Evolution of Epithelia Ovarian Tumors
Unknown
40 enrolled
A Multi-omics Study of Epithelial Ovarian Cancer
Unknown
80 enrolled
Inherited Susceptible Genes Among Epithelial Ovarian Cancer
Unknown
1,000 enrolled
Ovaire01
Unknown
376 enrolled
Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
Unknown
750 enrolled
Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Unknown
60 enrolled
Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
Unknown
2,000 enrolled
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
Unknown
513 enrolled